Valsartan reduces risk of atrial fibrillation in heart failure

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1488, 2005-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Valsartan reduces heart failure hospitalisations and norepinephrine levels in patients with heart failure

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 340, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Valsartan reduces heart failure hospitalisations and norepinephrine levels in patients with heart failure

Inpharma, Vol. 1, Iss. 1315, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Ximelagatran reduces stroke risk in atrial fibrillation

Inpharma, Vol. 1, Iss. 1387, 2003-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Valsartan: In Chronic Heart Failure

By Wellington K. Goa K.L.

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 4, 2002-01 ,pp. : 267-274

Adis International

Access to resources Recommend Favorite

Valsartan for the treatment of heart failure

By Latini Roberto Masson Serge Staszewsky Lidia Maggioni Aldo P

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 181-193

Informa Healthcare

Access to resources Recommend Favorite